AMPH
Price
$26.68
Change
-$0.71 (-2.59%)
Updated
Sep 29 closing price
Capitalization
1.17B
40 days until earnings call
Intraday BUY SELL Signals
ZTS
Price
$70.32
Change
-$1.11 (-1.55%)
Updated
Sep 29, 04:59 PM (EDT)
Capitalization
29.52B
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMPH vs ZTS

AMPH vs ZTS Comparison Chart in %
View a ticker or compare two or three
VS
AMPH vs. ZTS commentary
Sep 30, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a StrongBuy and ZTS is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
AMPH vs ZTS: Fundamental Ratings
AMPH
ZTS
OUTLOOK RATING
1..100
2565
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
10
Undervalued
PROFIT vs RISK RATING
1..100
88100
SMR RATING
1..100
6918
PRICE GROWTH RATING
1..100
3964
P/E GROWTH RATING
1..100
1293
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZTS's Valuation (10) in the Pharmaceuticals Generic industry is somewhat better than the same rating for AMPH (61) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew somewhat faster than AMPH’s over the last 12 months.

AMPH's Profit vs Risk Rating (88) in the Pharmaceuticals Other industry is in the same range as ZTS (100) in the Pharmaceuticals Generic industry. This means that AMPH’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's SMR Rating (18) in the Pharmaceuticals Generic industry is somewhat better than the same rating for AMPH (69) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew somewhat faster than AMPH’s over the last 12 months.

AMPH's Price Growth Rating (39) in the Pharmaceuticals Other industry is in the same range as ZTS (64) in the Pharmaceuticals Generic industry. This means that AMPH’s stock grew similarly to ZTS’s over the last 12 months.

AMPH's P/E Growth Rating (12) in the Pharmaceuticals Other industry is significantly better than the same rating for ZTS (93) in the Pharmaceuticals Generic industry. This means that AMPH’s stock grew significantly faster than ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHZTS
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 2 days ago
51%
Declines
ODDS (%)
Bearish Trend 12 days ago
69%
Bearish Trend 6 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
67%
COMPARISON
Comparison
Sep 30, 2026
Stock price -- (AMPH: $26.68 vs. ZTS: $71.43)
Brand notoriety: AMPH: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMPH: 142% vs. ZTS: 67%
Market capitalization -- AMPH: $1.17B vs. ZTS: $29.52B
AMPH [@Pharmaceuticals: Generic] is valued at $1.17B. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $29.52B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 1 FA rating(s) are green while ZTS’s FA Score has 2 green FA rating(s).

  • AMPH’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 2 green, 3 red.
According to our system of comparison, both AMPH and ZTS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 4 TA indicator(s) are bullish while ZTS’s TA Score has 3 bullish TA indicator(s).

  • AMPH’s TA Score: 4 bullish, 4 bearish.
  • ZTS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AMPH is a better buy in the short-term than ZTS.

Price Growth

AMPH (@Pharmaceuticals: Generic) experienced а +9.70% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was +0.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.37%. For the same industry, the average monthly price growth was -3.37%, and the average quarterly price growth was +36.83%.

Reported Earning Dates

AMPH is expected to report earnings on Nov 09, 2026.

ZTS is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.37% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
AMPH
Daily Signal:
Gain/Loss:
ZTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIRC6.50N/A
N/A
Virco Manufacturing Corp
CBZ54.69-0.02
-0.04%
CBIZ
WES44.94-0.33
-0.73%
Western Midstream Partners LP
ALOY8.00-0.42
-4.99%
REalloys Inc.
ITOC0.27-0.02
-5.80%
iTonic Holdings Ltd.

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with PAHC. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-1.58%
PAHC - ZTS
58%
Loosely correlated
-0.70%
ELAN - ZTS
44%
Loosely correlated
+0.71%
AMPH - ZTS
36%
Loosely correlated
-2.59%
SNDL - ZTS
33%
Loosely correlated
-2.16%
HLN - ZTS
33%
Loosely correlated
-1.09%
More